Mersana Therapeutics, Inc. Share Price
MRSN
$6.99
-$0.02 (-0.36%) Last updated on 04 Sep, 2025 | 23:57 ISTMersana Therapeutics, Inc. Stock Performance
Open $6.85 | Prev. Close $7.01 | Circuit Range N/A |
Day Range $6.84 - $6.90 | Year Range $0.26 - $8.11 | Volume 340 |
Average Traded $6.86 |
Mersana Therapeutics, Inc. Share Price Chart
$6.99
About Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana Biosciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.
Mersana Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Sep-25 | $6.85 | $6.90 | +0.00% |
04-Sep-25 | $6.85 | $6.90 | -1.00% |
03-Sep-25 | $7.42 | $6.97 | -4.98% |
02-Sep-25 | $7.20 | $7.33 | -1.74% |
29-Aug-25 | $7.42 | $7.46 | -3.80% |
28-Aug-25 | $7.82 | $7.76 | +1.97% |
27-Aug-25 | $7.59 | $7.61 | +0.73% |
FAQs on Mersana Therapeutics, Inc. Share Price
Can I buy Mersana Therapeutics, Inc. shares in India?
What is the share price of Mersana Therapeutics, Inc.?
What is the 5 year returns of Mersana Therapeutics, Inc.?
What are the high & low stock price of Mersana Therapeutics, Inc. today?
What is the 52-week high and low of Mersana Therapeutics, Inc. stock?